Research

23-CNR-4162210-CQD-Hero-650×450 Dr Khorana
October 12, 2023/Cancer/Research

Study Delves into the Mechanisms Causing Venous Thromboembolism in Patients Receiving Immunotherapies

Clinicians highlight the need to educate patients about warning signs

23-CNR-4210969-CQD-Hero1-650×450 Dr Amarnath
October 6, 2023/Cancer/Research

Quality Metrics and Quality Improvement Program Can Improve Cervical Cancer Care

A new analysis emphasizes the value of a multi-disciplinary approach.

23-CNR-42100966-CQD-Hero2-650×450 Dr Miller ASTRO article
October 5, 2023/Cancer/Research

Epstein-Barr Virus Serologic Screening for Nasopharyngeal Carcinoma is Cost-Effective in Southern China

Use of MRI adds to cost but remains cost-effective due to higher sensitivity

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

23-CNR-4210967-CQD-Hero-Astro
October 4, 2023/Cancer/Research

Phase 1 Study Supports Dose-Escalating Preoperative SRS for Large Brain Metastases

This approach led to local control for patients with brain metastases more than 2 cm in diameter

23-CNR-4198910-CQD-Hero-650×450 smoldering MM article
September 29, 2023/Cancer/Research

Watch and Wait Still a Viable Option for Many Patients with Smoldering Myeloma

Strategies and risk models are evolving for this asymptomatic condition

23-CNR-4162208-CQD-Hero-650×450 Dr Valente
September 27, 2023/Cancer/Research

Risk of Local Recurrence of DCIS After Mastectomy Appears Unrelated to Margins

Retrospective study involves 18 years of follow-up and shows low risk of local recurrence.

23-CNR-4045267-CQD-Hero-650×450-v2 Dr Jagadeesh
September 12, 2023/Cancer/Research

Pirtobrutinib Shows Promise for Older, Heavily Pretreated Patients with CLL

Large trial shows efficacy and lower incidences of heart issues and bleeding events with novel non-covalent BTK inhibitor

23-CNR-4044613-CQD-Hero-650×450 MM article
August 22, 2023/Cancer/Research

Study Explores VTE Risk Among Patients with Multiple Myeloma During the Peri-Transplant Period

Patients with a prior history of VTA are at an increased risk of subsequent incidents, despite treatment with therapeutic anticoagulation

23-CNR-3965756-CQD-Hero-650×450 Dr Molina
August 1, 2023/Cancer/Research

Measuring Residual Disease in Leukemias: Improving on Current Assays is a Focus

Single-cell next-gen sequencing showing promise to improve sensitivity of MRD testing

BackPage 3 of 42Next

Advertisement

Ad